HPV
The firm hopes that Medicare coverage will facilitate patient access to the NavDx test and spur its inclusion in practice guidelines for head and neck cancer.
Roche Gets FDA Approval for Cobas 5800 HPV Test
The test is intended for routine cervical cancer screening, including triage of cytology, co-testing with cytology, and HPV primary screening.
Abbott Molecular HPV Test Nabs FDA Approval
The test provides information on five risk groups covering the 14 cancer-causing genotypes of human papillomavirus.
Gates Foundation Awards Multiple Grants for Omics, Dx Projects in August
Awardees include Quantigen, Sherlock Biosciences, the Netherlands National Institute for Public Health and the Environment, Stanford University, and Rutgers University.
The firm is offering its epiCervix assay in the US as a laboratory-developed test to be used alongside human papillomavirus screening.